Company Filing History:
Years Active: 2000-2004
Title: Innovations by XiaQiang Hong
Introduction
XiaQiang Hong is a notable inventor based in Danvers, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of immunodiagnosis related to heartworm infections in mammals. With a total of 2 patents, his work has implications for both veterinary medicine and molecular biology.
Latest Patents
One of XiaQiang Hong's latest patents involves a glycoprotein of 31-33 kDa, referred to as DiT33. This invention represents a member of the family of putative pepsin inhibitors, which includes other known members such as Ov33, Bm33, and Av33. The patent outlines the use of DiT33 or Ov33, either as a recombinant fusion or non-fusion protein, to monitor antibody responses for immunodiagnosis of heartworm infection in mammals. Additionally, antibodies reactive with DiT33 or Ov33 can be utilized to detect the DiT33 antigen, further aiding in the diagnosis of heartworm infections.
Career Highlights
XiaQiang Hong is currently employed at New England Biolabs, Inc., a company renowned for its contributions to molecular biology and biotechnology. His work at this institution has allowed him to focus on innovative solutions that address critical health issues in animals.
Collaborations
Some of his notable coworkers include Francine B Perler and Jhon Santiago Mejia. Their collaborative efforts contribute to the advancement of research and development in the field.
Conclusion
XiaQiang Hong's innovative work in biotechnology, particularly in the area of heartworm immunodiagnosis, showcases his commitment to advancing medical science. His patents reflect a significant contribution to the understanding and treatment of parasitic infections in mammals.